Nevro Files Patent Suit Against Stimwave
Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.
You may also be interested in...
Nevro and Boston Scientific have resolved a patent dispute involving spinal cord stimulation technologies.
In the global pain management market, spinal cord stimulation (SCS) systems are expected to continue to be the fastest-growing segment with increasing competition among device manufacturers to develop innovative, targeted therapies. In this second article of a two-part series, we'll discuss the competitive landscape in the SCS market, the key players, emerging companies and their respective technologies.
The US FDA released updated safety information on Endologix Inc.’s AFX2 Endovascular abdominal aortic aneurysm (AAA) graft system on Tuesday. Previous devices in the product line have been associated with an increased risk of abnormal bleeding.